Pulsatile drug delivery for desired biopharmaceutical performance: Insights to achieve ideal pharmacokinetics, encourage patient compliance and generate new intellectual property.
- Focus on the use of oral pulsatile release design as a way to leverage chronotherapy, mimic bid or tid dosing, create a challenge to generic competition
- Timed delivery of two different active ingredients and provide both quick onset of action and quick termination of action
- Target delivery to a specific GI site of action
- Adare Proprietary Pulsatile Release Technology featured case studies to be presented
Luigi Boltri, R&D Director, Innovation and Technology Liaison, Adare Pharmaceuticals